Malignant Buccal Mucosa Neoplasm
Associated Genetic Biomarkers
NCI Definition: A primary or metastatic malignant neoplasm involving the buccal mucosa. 
There is 1 clinical trial for malignant buccal mucosa neoplasm, of which 0 are open and 1 is completed or closed. Of the trial that contains malignant buccal mucosa neoplasm as an inclusion criterion, 1 is phase 1/phase 2 (0 open).
CDKN2A and HPV are the most frequent gene inclusion criteria for malignant buccal mucosa neoplasm clinical trials .
Aminolevulinic acid and photodynamic therapy are the most common interventions in malignant buccal mucosa neoplasm clinical trials.
2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.